Pegasus Tech Ventures today announced the launch of a JPY 10 billion ($60 million U.S.) corporate venture capital, or CVC, fund. The San Jose, Calif.-based venture capital firm launched the fund with CYBERDYNE Inc.
The fund will invest in startups developing technologies across robotics, physical AI, healthcare, automation, and intelligent systems. It will have a particular focus on advancing CYBERDYNE’s vision for “human-cyber-physical space” (HCPS) cybernics, fusing humans, artificial intelligence, robotics, and information systems.
Pegasus will serve as the general partner of the new CVC fund, and CYBERDYNE will participate as the sole limited partner. Tsukuba, Japan-based CYBERDYNE will use Pegasus’ venture capital-as-a-service (VCaaS) network of startups, investors, and corporate partners.
“Robotics and intelligent systems are becoming increasingly important in addressing some of the world’s most pressing challenges,” stated Dr. Anis Uzzaman, founder and CEO of Pegasus Tech Ventures. “Through our venture capital-as-a-service platform, we look forward to connecting CYBERDYNE with leading entrepreneurs, breakthrough technologies, and strategic opportunities from Silicon Valley and innovation ecosystems that align with their long-term vision.”
Pegasus Tech Ventures bridges global innovators #
For more than a decade, Pegasus Tech Ventures said it has served as a bridge connecting corporations across Asia with Silicon Valley and the broader global innovation ecosystem. Through its VCaaS platform, the company provides its partners with access to strategic relationships with some of the world’s most promising technology companies. Pegasus manages more than 40 funds and over $2 billion in assets. It has invested in more than 300 startups, including SpaceX, OpenAI, Anthropic, Airbnb, Coinbase, and X (formerly Twitter).
CYBERDYNE and Pegasus said they will accelerate strategic investments, technology partnerships, and new business opportunities in emerging sectors.
CYBERDYNE hopes to collaborate with startups #
Founded in 2004, CYBERDYNE said it has expertise in cybernics, the combination of human biology and technology “to enhance, expand, and regenerate physical and cognitive functions.” The company has applied its technologies across healthcare, rehabilitation, labor support, disaster response, and industrial robotics.
Its flagship product is the Hybrid Assistive Limb (HAL), an assistive device that detects and responds to bioelectric signals from the wearer. HAL has been widely adopted in Japan and overseas across a broad range of applications, particularly in the medical and healthcare sectors.
Through the Pegasus partnership, CYBERDYNE said it wants to collaborate with startups and innovation ecosystems worldwide while addressing societal challenges such as aging populations, workforce shortages, and increasing healthcare demands.
“CYBERDYNE is committed to advancing HCPS Cybernics with physical AI and creating new value by fusing humans, AI-robotics, and information systems,” said Yoshiyuki Sankai, the founder and CEO of CYBERDYNE. “By partnering with Pegasus Tech Ventures and leveraging its global innovation network, we look forward to accelerating technology development, business co-creation, and global expansion opportunities.”